When examining the methylation status in chronic T2DM with and without diabetic retinopathy compared to T2DM with shorter disease duration, differential methylation of S100A13 was found in diabetic retinopathy, and S100A13 was identified as a possible biomarker [51]. Here, S100A13 is linked to type 2 diabetes mellitus.